Latest News and Press Releases
Want to stay updated on the latest news?
-
NeOnc(NASDAQ: NTHI) is rapidly emerging as a development-stage neuro-oncology innovator
-
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
Wall St analysts are rating NeOnc Technologies (NASDAQ:NTHI) a “Buy”, as institutional investors and company insiders are buying
-
Insiders are buying shares of $NTHI, $RIVN, $SRAD, $NWBI, and $FGBI